What is the management plan for a type 1 diabetic patient on Lantus (insulin glargine) 10 units nightly and Admelog (insulin lispro) 3 units before meals?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Type 1 Diabetes Management Plan for Patient on Lantus and Admelog

For a type 1 diabetic patient on Lantus 10 units nightly and Admelog 3 units before meals, the management plan should include carbohydrate counting to match mealtime insulin, regular blood glucose monitoring, and insulin dose adjustments based on glycemic patterns to optimize control and reduce complications. 1, 2

Current Insulin Regimen Assessment

The patient is currently on:

  • Basal insulin: Lantus (insulin glargine) 10 units at bedtime
  • Bolus insulin: Admelog (insulin lispro) 3 units before meals

This represents a basal-bolus regimen that aligns with current guidelines for type 1 diabetes management 1. However, several aspects need evaluation:

  1. Basal insulin adequacy: The 10 units of Lantus may need adjustment based on fasting and overnight glucose patterns
  2. Bolus insulin dosing: The fixed 3-unit dose before meals may not be optimal for varying carbohydrate intake
  3. Insulin-to-carbohydrate ratio (ICR): This should be established for proper meal coverage

Blood Glucose Monitoring Plan

  • Frequency: Minimum 4 times daily (before meals and bedtime) 2
  • Additional checks: 2 hours after meals to assess postprandial control and during suspected hypoglycemia
  • Overnight checks: Periodic 2-3 AM checks to assess for nocturnal hypoglycemia
  • Consider CGM: If available, continuous glucose monitoring would provide more comprehensive data 1

Insulin Dose Adjustment Algorithm

Basal Insulin (Lantus) Adjustment:

  • Target fasting glucose: 80-130 mg/dL 1
  • Adjustment protocol:
    • If fasting glucose consistently >130 mg/dL for 3 days: Increase by 2 units
    • If fasting glucose consistently <80 mg/dL or nocturnal hypoglycemia occurs: Decrease by 2 units
    • Maximum adjustment: 10-20% of current dose at one time 1

Bolus Insulin (Admelog) Adjustment:

  • Establish insulin-to-carbohydrate ratio (ICR):
    • Starting point: 1 unit per 15g carbohydrate (adjust based on response) 2
    • Teach patient to count carbohydrates and calculate pre-meal doses 1
  • Correction factor:
    • Initial recommendation: 1 unit lowers blood glucose by 50 mg/dL 2
    • Formula: (Pre-meal glucose - target glucose) ÷ correction factor = correction dose

Hypoglycemia Management

  • Mild/moderate hypoglycemia (<70 mg/dL):

    • Treat with 15g fast-acting carbohydrate (glucose tablets preferred)
    • Recheck in 15 minutes; repeat treatment if still <70 mg/dL 1
    • Follow with a small protein-containing snack if next meal is >1 hour away
  • Severe hypoglycemia:

    • Ensure glucagon is available and teach family/friends how to administer
    • If unconscious or unable to swallow: Use glucagon injection

Meal Planning

  • Carbohydrate consistency: While flexible dosing is possible, maintaining some consistency in carbohydrate intake can help with glucose management 1
  • Meal timing: With rapid-acting insulin (Admelog), meals should be consumed within 15 minutes of injection 1
  • Pre-meal insulin timing: Administer Admelog 15 minutes before eating for optimal postprandial control 2

Physical Activity Considerations

  • Pre-exercise adjustments:
    • For planned exercise: Reduce pre-meal Admelog by 25-50% for the meal before activity
    • For prolonged activity: Consider additional carbohydrate intake (15-30g per hour of moderate activity)
  • Post-exercise vigilance: Monitor for delayed hypoglycemia up to 24 hours after significant activity 1

Sick Day Management

  • Never discontinue insulin during illness
  • More frequent monitoring: Check glucose every 2-4 hours
  • Supplemental insulin: Use correction doses of Admelog for high glucose readings
  • Check for ketones: When glucose is >250 mg/dL or during illness
  • Hydration: Maintain fluid intake to prevent dehydration

Follow-up and Monitoring

  • HbA1c testing: Every 3 months
  • Target HbA1c: <7.0% (individualized based on hypoglycemia risk) 1
  • Regular provider visits: Every 3-4 months to review glucose patterns and adjust regimen

Common Pitfalls to Avoid

  1. Fixed bolus dosing: The current fixed 3-unit dose of Admelog before meals doesn't account for varying carbohydrate intake, which can lead to hypo- or hyperglycemia. Implement carbohydrate counting instead 1.

  2. Overbasalization: Relying too heavily on basal insulin while underutilizing bolus insulin can lead to weight gain and increased hypoglycemia risk 1.

  3. Ignoring pattern management: Failing to identify and address recurring glucose patterns can prevent optimal control. Review glucose logs regularly to identify patterns 2.

  4. Insulin stacking: Administering correction doses too frequently can lead to insulin stacking and subsequent hypoglycemia. Wait at least 3-4 hours between correction doses 2.

  5. Timing of Lantus: While typically given at bedtime, research shows that morning or dinner administration may be equally effective and sometimes preferable for preventing nocturnal hypoglycemia 3, 4.

This management plan provides a structured approach to optimize glycemic control while minimizing the risk of hypoglycemia for this type 1 diabetic patient on Lantus and Admelog.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.